Sen­a­tor asks FTC to in­ves­ti­gate Amerisource­Ber­gen over abor­tion pill dis­tri­b­u­tion plans

Sen. Tam­my Duck­worth (D-IL) has asked the Fed­er­al Trade Com­mis­sion to in­ves­ti­gate Amerisource­Ber­gen af­ter re­ports that the com­pa­ny might not dis­trib­ute mifepri­s­tone to re­tail phar­ma­cies in some states while still sell­ing them to health­care providers, Politi­co re­port­ed on Mon­day.

In her let­ter to the FTC, first pub­lished by Politi­co, Duck­worth said the com­pa­ny could be us­ing “its mo­nop­o­lis­tic pow­er” by re­fus­ing to sell the drug to cer­ti­fied phar­ma­cies. Amerisource­Ber­gen is the sole whole­sale dis­trib­u­tor of the brand name ver­sion of the drug mifepri­s­tone, called Mifeprex, to re­tail phar­ma­cies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER